These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 23887713)

  • 21. High phospho-histone H3 expression uniquely predicts favorable survival among four markers of cellular proliferation in colorectal cancer.
    Koshino A; Inoue S; Sugimura-Nagata A; Nishiyama T; Murakami H; Ito H; Riku M; Inoko A; Ebi M; Ogasawara N; Tsuzuki T; Kasugai K; Kasai K; Inaguma S
    Pathol Int; 2021 May; 71(5):316-324. PubMed ID: 33631042
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Impact of Phosphohistone-H3-Assisted Mitotic Count and Ki67 Score in the Determination of Tumor Grade and Prediction of Distant Metastasis in Well-Differentiated Pancreatic Neuroendocrine Tumors.
    Ozturk Sari S; Taskin OC; Gundogdu G; Yegen G; Onder S; Keskin M; Saglam S; Ozluk Y; Gulluoglu M; Mete O
    Endocr Pathol; 2016 Jun; 27(2):162-70. PubMed ID: 26936845
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mitotic Index Determined by Phosphohistone H3 Immunohistochemistry for Precise Grading in Follicular Lymphoma.
    Bedekovics J; Irsai G; Hegyi K; Beke L; Krenács L; Gergely L; Méhes G
    Appl Immunohistochem Mol Morphol; 2018 Sep; 26(8):579-585. PubMed ID: 27997502
    [TBL] [Abstract][Full Text] [Related]  

  • 24. p27(kip1) and Ki-67 (MIB1) immunohistochemical expression in radical prostatectomy specimens of patients with clinically localized prostate cancer.
    Revelos K; Petraki C; Gregorakis A; Scorilas A; Papanastasiou P; Tenta R; Koutsilieris M
    In Vivo; 2005; 19(5):911-20. PubMed ID: 16097446
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predicting short-term recurrence in pituitary adenomas: Phosphohistone-H3 (Ser 10) proves an effective biomarker.
    Li C; Wei L; Li L; Wang J; Li R; Zhang Q; Zhou D
    Clin Neuropathol; 2020; 39(2):70-79. PubMed ID: 31724532
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of Ki-67 (MIB-1) and GLUT-1 proteins in non-advanced prostatic cancer.
    Luczynska E; Gasinska A; Wilk W
    Pol J Pathol; 2012 Dec; 63(4):272-7. PubMed ID: 23359198
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of mitotic figures and G2+ tumor nuclei with histone markers correlates with worse overall survival in patients with Merkel cell carcinoma.
    Henderson SA; Tetzlaff MT; Pattanaprichakul P; Fox P; Torres-Cabala CA; Bassett RL; Prieto VG; Richards HW; Curry JL
    J Cutan Pathol; 2014 Nov; 41(11):846-52. PubMed ID: 25263506
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Paradoxical results obtained with Ki67-labeling and PHH3-mitosis index in glial tumors: a literature analysis.
    Elmaci İ; Altinoz MA; Bolukbasi FH; Yapicier O; Sav A
    Clin Neuropathol; 2017; 36(6):272-282. PubMed ID: 28853695
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of p120, Ki-67 and PCNA as proliferation biomarkers in imprint smears of prostate carcinoma and their prognostic value.
    Bantis A; Giannopoulos A; Gonidi M; Liossi A; Aggelonidou E; Petrakakou E; Athanassiades P; Athanassiadou P
    Cytopathology; 2004 Feb; 15(1):25-31. PubMed ID: 14748788
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mitotic count by phosphohistone H3 immunohistochemical staining predicts survival and improves interobserver reproducibility in well-differentiated neuroendocrine tumors of the pancreas.
    Voss SM; Riley MP; Lokhandwala PM; Wang M; Yang Z
    Am J Surg Pathol; 2015 Jan; 39(1):13-24. PubMed ID: 25353284
    [TBL] [Abstract][Full Text] [Related]  

  • 31. EPIGENETIC CHANGES - HISTONE 3 PHOSPHORYLATION - EPITHELIAL OVARIAN TUMORS.
    Munjishvili V; Barabadze E; Muzashvili T; Gachechiladze M; Burkadze G
    Georgian Med News; 2019 Sep; (294):128-131. PubMed ID: 31687964
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ki-67 in screen-detected, low-grade, low-stage prostate cancer, relation to prostate-specific antigen doubling time, Gleason score and prostate-specific antigen relapse after radical prostatectomy.
    Khatami A; Hugosson J; Wang W; Damber JE
    Scand J Urol Nephrol; 2009; 43(1):12-8. PubMed ID: 18949633
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protein expression of p53, bcl-2, and KI-67 (MIB-1) as prognostic biomarkers in patients with surgically treated, clinically localized prostate cancer.
    Moul JW; Bettencourt MC; Sesterhenn IA; Mostofi FK; McLeod DG; Srivastava S; Bauer JJ
    Surgery; 1996 Aug; 120(2):159-66; discussion 166-7. PubMed ID: 8751578
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mitosis count and number of cancer cells in cases of primary pulmonary adenocarcinoma: Correlations among phosphorylated histone 3, number of cancer cells, nuclear grade, pathologic features and prognosis.
    Inoue T; Nakazato Y; Karube Y; Maeda S; Kobayashi S; Chida M
    Pathol Int; 2018 Mar; 68(3):159-166. PubMed ID: 29393583
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Utility of Phosphohistone H3 (PHH3) in Follicular Lymphoma Grading: A Comparative Study With Ki-67 and H&E Mitotic Count.
    Khieu ML; Broadwater DR; Aden JK; Coviello JM; Lynch DT; Hall JM
    Am J Clin Pathol; 2019 May; 151(6):542-550. PubMed ID: 30788495
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phosphorylated histone H3, Ki-67, p21, fatty acid synthase, and cleaved caspase-3 expression in benign and atypical granular cell tumors.
    Kapur P; Rakheja D; Balani JP; Roy LC; Amirkhan RH; Hoang MP
    Arch Pathol Lab Med; 2007 Jan; 131(1):57-64. PubMed ID: 17227124
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of phospho-histone H3 in Asian triple-negative breast cancer using multiplex immunofluorescence.
    Lai CPT; Yeong JPS; Tan AS; Ong CHC; Lee B; Lim JCT; Thike AA; Iqbal J; Dent RA; Lim EH; Tan PH
    Breast Cancer Res Treat; 2019 Nov; 178(2):295-305. PubMed ID: 31410680
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of Phosphohistone H3 Cutoff Values Corresponding to Original WHO Grades but Distinguishable in Well-Differentiated Gastrointestinal Neuroendocrine Tumors.
    Kim MJ; Kwon MJ; Kang HS; Choi KC; Nam ES; Cho SJ; Park HR; Min SK; Seo J; Choe JY; Park HC
    Biomed Res Int; 2018; 2018():1013640. PubMed ID: 29780816
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PSCA, Cox-2, and Ki-67 are independent, predictive markers of biochemical recurrence in clinically localized prostate cancer: a retrospective study.
    Kim SH; Park WS; Park BR; Joo J; Joung JY; Seo HK; Chung J; Lee KH
    Asian J Androl; 2017; 19(4):458-462. PubMed ID: 27232854
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of Proliferation Markers Ki67 and Phosphohistone-H3 (pHH3) in Breast Ductal Carcinoma In Situ.
    Bosch DE; Kilgore MR; Schmidt RA; Swanson PE; Rendi MH; Chang OH
    Appl Immunohistochem Mol Morphol; 2017 Sep; 25(8):543-547. PubMed ID: 28885232
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.